1. Home
  2. NABL vs WVE Comparison

NABL vs WVE Comparison

Compare NABL & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NABL
  • WVE
  • Stock Information
  • Founded
  • NABL 2000
  • WVE 2012
  • Country
  • NABL United States
  • WVE Singapore
  • Employees
  • NABL N/A
  • WVE N/A
  • Industry
  • NABL Computer Software: Prepackaged Software
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • NABL Technology
  • WVE Health Care
  • Exchange
  • NABL Nasdaq
  • WVE Nasdaq
  • Market Cap
  • NABL 1.9B
  • WVE 1.7B
  • IPO Year
  • NABL N/A
  • WVE 2015
  • Fundamental
  • Price
  • NABL $10.31
  • WVE $11.13
  • Analyst Decision
  • NABL Buy
  • WVE Strong Buy
  • Analyst Count
  • NABL 3
  • WVE 10
  • Target Price
  • NABL $13.17
  • WVE $21.60
  • AVG Volume (30 Days)
  • NABL 731.4K
  • WVE 759.9K
  • Earning Date
  • NABL 03-03-2025
  • WVE 03-05-2025
  • Dividend Yield
  • NABL N/A
  • WVE N/A
  • EPS Growth
  • NABL 72.50
  • WVE N/A
  • EPS
  • NABL 0.20
  • WVE N/A
  • Revenue
  • NABL $458,053,000.00
  • WVE $53,610,000.00
  • Revenue This Year
  • NABL $12.07
  • WVE N/A
  • Revenue Next Year
  • NABL $10.50
  • WVE $48.58
  • P/E Ratio
  • NABL $51.55
  • WVE N/A
  • Revenue Growth
  • NABL 11.93
  • WVE N/A
  • 52 Week Low
  • NABL $8.92
  • WVE $4.25
  • 52 Week High
  • NABL $15.49
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • NABL 64.61
  • WVE 44.53
  • Support Level
  • NABL $9.81
  • WVE $10.79
  • Resistance Level
  • NABL $10.04
  • WVE $11.78
  • Average True Range (ATR)
  • NABL 0.21
  • WVE 0.69
  • MACD
  • NABL 0.03
  • WVE 0.05
  • Stochastic Oscillator
  • NABL 93.98
  • WVE 43.95

About NABL N-able Inc.

N-able Inc is a provider of cloud-based software solutions for managed service providers (MSPs), enabling them to support digital transformation and growth for small and medium-sized enterprises. With a flexible technology platform and powerful integrations, N-able makes it easy for MSPs to monitor, manage, and protect their end-customer systems, data, and networks. The company's growing portfolio of management, security, automation, and data protection solutions is built for IT services management professionals. Geographically, the majority of revenue is from the United States. it also has a presence in the United Kingdom and all other International regions.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: